| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.40B | +2.2% |
| Cost of Revenue | $2.69B | +6.9% |
| Gross Profit | $3.71B | -0.9% |
| R&D Expense | $469.0M | -11.2% |
| SG&A Expense | $1.76B | -7.0% |
| Interest Expense | $520.0M | -1.3% |
| Pre-tax Income | $807.0M | +19.9% |
| Income Tax | -$57.0M | +83.7% |
| Net Income | $864.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $675.0M | -2.6% |
| Accounts Receivable | $1.36B | -22.1% |
| Inventory | $1.32B | +0.5% |
| Current Assets | $4.35B | -3.5% |
| Total Assets | $13.10B | +8.6% |
| Current Liabilities | $2.72B | -6.9% |
| Long-term Debt | $8.88B | +1.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $939.0M | +17.5% |
| Capital Expenditures | $175.0M | -30.3% |
| Investing Cash Flow | -$513.0M | -97.3% |
| Financing Cash Flow | -$368.0M | +35.3% |
| Free Cash Flow | $764.0M | +39.4% |
| -15.5% |
| EPS (Basic) | $3.36 | -16.2% |
| EPS (Diluted) | $3.33 | -16.5% |
| Total Liabilities |
| $12.63B |
| +4.1% |
| Stockholders' Equity | $472.0M | +774.3% |